alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › non-invasive

non-invasive

2 studies tagged non-invasive, dated 2008-06-23 to 2023-09-12. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 2023-09-12
  2. Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood 2008-06-23

Studies

2 studies carry this tag.

Date range

2008 to 2023

Top journals

  • Journal of the neurological sciences 1
  • Methods (San Diego, Calif.) 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of the neurological sciences 2023-09-12 Biomarkers

    Plasma p-tau181 levels were influenced by the presence of underlying AD pathology, independently from the cognitive status and were highly accurate in differentiating SCD-MCI patients who were carriers of AD pathology from non-carriers.

  2. Non-invasive, ultra-sensitive, high-throughput assays to quantify rare biomarkers in the blood

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Methods (San Diego, Calif.) 2008-06-23 Biomarkers

    Many diseases are easier to treat and control when detected at an early stage of disease progression.

All topic tags with their study counts